areta conceives alliances as a source of innovation and a strategic choice according to its mission.
areta actively pursues alliances:
areta’s partners include pharmaceutical, biotechnological and consultancy services companies in the field of life sciences.
Companies currently partnering with areta:
accuro biologics is a UK company providing expert services in antibody engineering. The company uses its know-how and technical expertise to deliver wide-ranging project types in recombinant antibody gene manipulation and expression.
MOLMED S.p.A. is a biotechnology company focused on research, development and clinical validation of novel antitumour therapies. MOLMED’s pipeline includes two novel therapeutics in clinical development: TK, a cellbased therapy enabling bone marrow transplants from partially compatible donors, in Phase III in high-risk acute leukaemias; NGR-hTNF, a novel vascular targeting agent (VTA), in Phase III for malignant pleural mesothelioma and in Phase II in five more indications: colorectal, lung (small-cell and non-small-cell), liver and ovarian cancer.
MOLMED is headquartered at the San Raffaele Biomedical Science Park in Milan, Italy.
NeuroZone is service company for high content cell-based assays in the neuroscience / stem cell drug market.
The company delivers purified primary cell cultures from the CNS, Stem cells and provides customized multiparametric compound validation services (in vitro/ in vivo) for preclinical projects.